The National Core Studies (NCS) Immunity Programme, one of the six National Core Studies set up by the Government Office for Science in 2020 to respond to important strategic, policy and operational questions about COVID-19, came to its conclusion in March 2023.
The British Society for Immunology is proud to have supported NCS Immunity, which was led by Paul Moss, Professor of Haematology at the University of Birmingham, and funded by UK Research and Innovation.
As part of our commitment to supporting NCS Immunity’s communications activities, we have produced an impact report setting out how the programme achieved its aim of deepening our understanding of immunity against COVID-19 and its long-term benefits.
It describes how the programme delivered rapid benefit to the public, how its teams forged new productive collaborations and paved the way for future discoveries, as well as how patients and the public were involved to ensure the programme’s research delivered maximum benefit to those in most need. NCS Immunity’s patient and public involvement was delivered by the BSI, and a separate report we published in December 2022 describes this activity in further detail.
The COVID-19 National Core Studies were a key part of the UK’s pandemic response. They enabled the UK to use health data and research to inform responses to COVID-19, as well as accelerating progress to establish a world-leading health data and research infrastructure for the future. NCS Immunity was funded by UK Research and Innovation. Find out more about the programme here.